Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Gliomas are the most common type of primary brain tumors. Their management options and outcomes depend significantly on the underlying molecular-marker profile. Traditionally, molecular markers are determined through pathological testing on a tissue specimen acquired through biopsy. Several Magnetic Resonance Imaging (MRI) based Deep Learning (DL) methods offer a promising, non-invasive approach t...
Accurate differentiation between benign and malignant thyroid nodules remains challenging in clinical practice. Current deep learning approaches predo...
INTRODUCTION: Adrenocortical tumors (ACTs) comprise adrenocortical adenomas (ACAs) and adrenocortical carcinomas (ACCs); the latter are highly aggress...
CONTEXT: Accurate preoperative prediction of occult lymph node metastasis (OLNM) in clinically lymph node negative (cN0) papillary thyroid carcinoma (...
Graves' disease (GD) is an autoimmune entity that had an unchanged treatment paradigm for more than half a century with radioactive iodine, antithyroi...
Hormone-dependent cancers such as prostate, breast, and endometrial carcinomas rely on nuclear hormone receptors to sustain lineage identity and growt...
Convolutional Neural Networks are widely used in lung cancer detection for more than a decade. However, it suffers from preserving spatial relationshi...
BACKGROUNDPrimary therapy for high-risk bladder cancer (BCa) is repeated instillations of the tuberculosis vaccine Bacillus Calmette-Guérin (BCG). Alt...
BACKGROUND: Artificial intelligence (AI) and machine learning (ML) tools are increasingly embedded in cancer care, yet the scope of U.S. Food and Drug...
Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) has been associated with the development of various malignant tumors. H...
Radiotherapy (RT) remains a cornerstone of cancer management but is fundamentally constrained by normal tissue toxicity, intrinsic and acquired radior...
Programmed cell death (PCD) and cellular immunity play pivotal roles in colorectal cancer (CRC) progression; understanding their crosstalk and identif...
The 6th edition of the WHO Classification of Breast Tumours introduces both major and minor changes based on recent advances in our understanding of b...
AIMS: Hepatocellular carcinoma (HCC) represents a major global health burden. Tumor-associated autoantibodies (TAAs) represent promising biomarkers fo...
Cancer remains one of the leading causes of death worldwide and continues to pose a serious public health challenge. The limited success of many curre...
Gastroenterology offers a broad, evidence-based range of preventive measures that goes beyond colorectal cancer screening. As a specialty of systemic ...
OBJECTIVES: To characterize clinical-pathologic tumor features associated with artificial intelligence (AI)-generated risk scores from prior-year scre...